Cardiovascular Complications Following Thoracic Surgery

Thoracic Surgery Clinics

Volumn 25, Issue 4, 2015, Pages 371-392

  Keshava, Hari B ^a,b   Boffa, Daniel J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Myocardial infarction; Pulmonary embolism

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; AMIODARONE; APIXABAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANGRELOR; CLOPIDOGREL; DABIGATRAN; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDOXABAN; EPTIFIBATIDE; FIBRINOLYTIC AGENT; FLECAINIDE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; PRASUGREL; PROCAINAMIDE; RIVAROXABAN; TICAGRELOR; TIROFIBAN;

ANTICOAGULATION; ATRIAL FIBRILLATION; BLOOD CLOT LYSIS; CARDIOVASCULAR DISEASE; CARDIOVERSION; COMPRESSION STOCKING; CORONARY STENT; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; ECHOCARDIOGRAPHY; ESOPHAGUS RESECTION; EXERCISE TEST; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART INFARCTION; HIATUS HERNIA; HOSPITAL DISCHARGE; HUMAN; LOBECTOMY; LUNG EMBOLISM; LUNG RESECTION; LUNG SURGERY; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PULMONARY ARTERY THROMBOSIS; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; STENT THROMBOSIS; THORAX SURGERY; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; POSTOPERATIVE COMPLICATION;

CARDIOVASCULAR DISEASES; HUMANS; POSTOPERATIVE COMPLICATIONS; THORACIC SURGICAL PROCEDURES;

EID: 84945275402     PISSN: None     EISSN: 15585069     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2015.07.001     Document Type: Review

References (111)

1. Fleisher L.A., Fleischmann K.E., Auerbach A.D., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014, 64:e77-e137.
2. Boffa D.J., Allen M.S., Grab J.D., et al. Data from the Society of Thoracic Surgeons general thoracic surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 2008, 135:247-254.
3. Wright C.D., Kucharczuk J.C., O'Brien S.M., et al. Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons general thoracic surgery database risk adjustment model. J Thorac Cardiovasc Surg 2009, 137:587-596. [discussion: 596].
4. Marret E., Miled F., Bazelly B., et al. Risk and protective factors for major complications after pneumonectomy for lung cancer. Interactive Cardiovasc Thorac Surg 2010, 10:936-939.
5. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007, 116:e418-e499.
6. Rentz J., Bull D., Harpole D., et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg 2003, 125:1114-1120.
7. Bailey S.H., Bull D.A., Harpole D.H., et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003, 75:217-222. [discussion: 222].
8. Lee T.H., Marcantonio E.R., Mangione C.M., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999, 100:1043-1049.
9. Devereaux P.J., Goldman L., Cook D.J., et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 2005, 173:627-634.
10. Brunelli A., Varela G., Salati M., et al. Recalibration of the revised cardiac risk index in lung resection candidates. Ann Thorac Surg 2010, 90:199-203.
11. Devereaux P.J., Xavier D., Pogue J., et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med 2011, 154:523-528.
12. Kamel H., Johnston S.C., Kirkham J.C., et al. Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction. Circulation 2012, 126:207-212.
13. Fihn S.D., Blankenship J.C., Alexander K.P., et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2014, 64:1929-1949.
14. Ronan G., Wolk M.J., Bailey S.R., et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Nucl Cardiol 2014, 21:192-220.
15. Ovrehus K.A., Jasinskiene J., Sand N.P., et al. Coronary calcification among 3477 asymptomatic and symptomatic individuals. Eur J Prev Cardiol 2015, [Epub ahead of print].
16. Loffroy R., Bernard S., Serusclat A., et al. Noninvasive assessment of the prevalence and characteristics of coronary atherosclerotic plaques by multidetector computed tomography in asymptomatic type 2 diabetic patients at high risk of significant coronary artery disease: a preliminary study. Arch Cardiovasc Dis 2009, 102:607-615.
17. Becker A., Leber A.W., Becker C., et al. Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: a prospective study in 716 patients over 8 years. BMC Cardiovasc Disord 2008, 8:27.
18. Ross A.F., Ueda K. Pulmonary hypertension in thoracic surgical patients. Curr Opin Anaesthesiol 2010, 23:25-33.
19. Hall A., Older P. Cardiopulmonary exercise testing accurately predicts risk of major surgery including esophageal resection: letter 1. Ann Thorac Surg 2009, 87:670-671.
20. Husain Z., Palani G., Cabrera R., et al. Hemodynamic response, arrhythmic risk, and overall safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients. Int J Cardiovasc Imaging 2012, 28:1841-1849.
21. Leitha T., Gwechenberger M., Falger-Banyai S. Does dyspnoea during dipyridamole cardiac stress testing indicate bronchospasm and is the pretest clinical history predictive of this side-effect?. Eur J Nucl Med 1995, 22:1408-1410.
22. Balan K.K., Critchley M. Is the dyspnea during adenosine cardiac stress test caused by bronchospasm?. Am Heart J 2001, 142:142-145.
23. Fricke E., Esdorn E., Kammeier A., et al. Respiratory resistance of patients during cardiac stress testing with adenosine: is dyspnea a sign of bronchospasm?. J Nucl Cardiol 2008, 15:94-99.
24. Reyes E., Loong C.Y., Wechalekar K., et al. Side effect profile and tolerability of adenosine myocardial perfusion scintigraphy in patients with mild asthma or chronic obstructive pulmonary disease. J Nucl Cardiol 2007, 14:827-834.
25. Popescu W.M. Perioperative management of the patient with a coronary stent. Curr Opin Anaesthesiol 2010, 23:109-115.
26. Douketis J.D., Spyropoulos A.C., Spencer F.A., et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141:e326S-e350S.
27. Grines C.L., Bonow R.O., Casey D.E., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007, 49:734-739.
28. Ceppa D.P., Welsby I.J., Wang T.Y., et al. Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection. Ann Thorac Surg 2011, 92:1971-1976.
29. Cerfolio R.J., Minnich D.J., Bryant A.S. General thoracic surgery is safe in patients taking clopidogrel (Plavix). J Thorac Cardiovasc Surg 2010, 140:970-976.
30. Namasivayam V., Prasad G.A., Lutzke L.S., et al. The risk of endoscopic mucosal resection in the setting of clopidogrel use. ISRN Gastroenterol 2014, 2014:494157.
31. Jakobsen C.J., Bille S., Ahlburg P., et al. Preoperative metoprolol improves cardiovascular stability and reduces oxygen consumption after thoracotomy. Acta Anaesthesiol Scand 1997, 41:1324-1330.
32. Lai R.C., Xu M.X., Huang W.Q., et al. Beneficial effects of metoprolol on perioperative cardiac function of elderly esophageal cancer patients. Ai Zheng 2006, 25:609-613. [in Chinese].
33. Mangano D.T., Layug E.L., Wallace A., et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter study of perioperative ischemia research group. N Engl J Med 1996, 335:1713-1720.
34. Wijeysundera D.N., Duncan D., Nkonde-Price C., et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014, 64:2406-2425.
35. Dai N., Xu D., Zhang J., et al. Different beta-blockers and initiation time in patients undergoing noncardiac surgery: a meta-analysis. Am J Med Sci 2014, 347:235-244.
36. Talati R., Reinhart K.M., White C.M., et al. Outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery: a meta-analysis. Ann Pharmacother 2009, 43:1181-1188.
37. Anwaruddin S., Askari A.T., Saudye H., et al. Characterization of post-operative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv 2009, 2:542-549.
38. Fenstad E.R., Anavekar N.S., Williamson E., et al. Twist and shout: acute right ventricular failure secondary to cardiac herniation and pulmonary artery compression. Circulation 2014, 129:e409-e412.
39. Shimizu J., Ishida Y., Hirano Y., et al. Cardiac herniation following intrapericardial pneumonectomy with partial pericardiectomy for advanced lung cancer. Ann Thorac Cardiovasc Surg 2003, 9:68-72.
40. Ponten J.E., Elenbaas T.W., ter Woorst J.F., et al. Cardiac herniation after operative management of lung cancer: a rare and dangerous complication. Gen Thorac Cardiovasc Surg 2012, 60:668-672.
41. Terauchi Y., Kitaoka H., Tanioka K., et al. Inferior acute myocardial infarction due to acute cardiac herniation after right pneumonectomy. Cardiovasc Interv Ther 2012, 27:110-113.
42. Kamiyoshihara M., Nagashima T., Baba S., et al. Serial chest films are needed after a diagnosis of pneumopericardium because of risk of cardiac herniation. Ann Thorac Surg 2010, 90:1705-1707.
43. Kawamukai K., Antonacci F., Di Saverio S., et al. Acute postoperative cardiac herniation. Interactive Cardiovasc Thorac Surg 2011, 12:73-74.
44. Steinmann D., Rohr E., Kirschbaum A. Acute tension pneumothorax following cardiac herniation after pneumonectomy. Case Rep Med 2010, 2010:213818.
45. Holloway B., Mukadam M., Thompson R., et al. Cardiac herniation and lung torsion following heart and lung transplantation. Interactive Cardiovasc Thorac Surg 2010, 10:1044-1046.
46. Karalapillai D., Larobina M., Stevenson K., et al. A change of heart: acute cardiac dextroversion with cardiogenic shock after partial lung resection. Crit Care Resuscitation 2008, 10:140-143.
47. Kiev J., Parker M., Zhao X., et al. Cardiac herniation after intrapericardial pneumonectomy and subsequent cardiac tamponade. Am Surg 2007, 73:906-908.
48. Mehanna M.J., Israel G.M., Katigbak M., et al. Cardiac herniation after right pneumonectomy: case report and review of the literature. J Thorac Imaging 2007, 22:280-282.
49. Zandberg F.T., Verbeke S.J., Snijder R.J., et al. Sudden cardiac herniation 6 months after right pneumonectomy. Ann Thorac Surg 2004, 78:1095-1097.
50. Mason D.P., Quader M.A., Blackstone E.H., et al. Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome. J Thorac Cardiovasc Surg 2006, 131:711-718.
51. Ziomek S., Read R.C., Tobler H.G., et al. Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg 1993, 56:223-226. [discussion: 227].
52. Dentali F., Malato A., Ageno W., et al. Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. J Thorac Cardiovasc Surg 2008, 135:705-706.
53. Bosch D.J., Van Dalfsen Q.A., Mul V.E., et al. Increased risk of thromboembolism in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. Am J Surg 2014, 208:215-221.
54. Connolly G.C., Dalal M., Lin J., et al. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer. Lung Cancer 2012, 78:253-258.
55. Patel A., Anraku M., Darling G.E., et al. Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies. J Thorac Cardiovasc Surg 2009, 138:843-848.
56. Verhage R.J., van der Horst S., van der Sluis P.C., et al. Risk of thromboembolic events after perioperative chemotherapy versus surgery alone for esophageal adenocarcinoma. Ann Surg Oncol 2012, 19:684-692.
57. Scott W.J., Allen M.S., Darling G., et al. Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. J Thorac Cardiovasc Surg 2010, 139:976-981. [discussion: 981-3].
58. Boffa D.J., Dhamija A., Kosinski A.S., et al. Fewer complications result from a video-assisted approach to anatomic resection of clinical stage I lung cancer. J Thorac Cardiovasc Surg 2014, 148:637-643.
59. Cao C., Manganas C., Ang S.C., et al. A meta-analysis of unmatched and matched patients comparing video-assisted thoracoscopic lobectomy and conventional open lobectomy. Ann Cardiothorac Surg 2012, 1:16-23.
60. Flores R.M., Park B.J., Dycoco J., et al. Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg 2009, 138:11-18.
61. Daddi G., Milillo G., Lupattelli L., et al. Postoperative pulmonary embolism detected with multislice computed tomography in lung surgery for cancer. J Thorac Cardiovasc Surg 2006, 132:197-198.
62. National Clinical Guideline Centre A, Chronic C, National Institute for Health and Clinical Excellence: Guidance Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 2010, Royal College of Physicians (UK) National Clinical Guideline Centre - Acute and Chronic Conditions, London.
63. Brock H., Rieger R., Gabriel C., et al. Haemodynamic changes during thoracoscopic surgery the effects of one-lung ventilation compared with carbon dioxide insufflation. Anaesthesia 2000, 55:10-16.
64. Gould M.K., Garcia D.A., Wren S.M., et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141:e227S-e277S.
65. Agnelli G., Bolis G., Capussotti L., et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006, 243:89-95.
66. Giannoukas A.D., Labropoulos N., Michaels J.A. Compression with or without early ambulation in the prevention of post-thrombotic syndrome: a systematic review. Eur J Vasc Endovasc Surg 2006, 32:217-221.
67. Collins R., Scrimgeour A., Yusuf S., et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988, 318:1162-1173.
68. Vanek V.W. Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thigh-high to knee-high sleeves. Am Surg 1998, 64:1050-1058.
69. Konstantinides S.V., Torbicki A., Agnelli G., et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014, 35:3033-3069. 3069a-k.
70. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet 1975, 2:45-51.
71. Mismetti P., Laporte S., Darmon J.Y., et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001, 88:913-930.
72. Arnold J.D., Dart B.W., Barker D.E., et al. Gold Medal Forum winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients. Am Surg 2010, 76:563-570.
73. Phung O.J., Kahn S.R., Cook D.J., et al. Dosing frequency of unfractionated heparin thromboprophylaxis: a meta-analysis. Chest 2011, 140:374-381.
74. Ikesaka R., Delluc A., Le Gal G., et al. Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: a systematic review and meta-analysis. Thromb Res 2014, 133:682-687.
75. Jamal M.H., Corcelles R., Shimizu H., et al. Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience. Surg Endosc 2015, 29:376-380.
76. Sarosiek S., Crowther M., Sloan J.M. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med 2013, 173:513-517.
77. Srivastava S.D., Eagleton M.J., Greenfield L.J. Diagnosis of pulmonary embolism with various imaging modalities. Semin Vasc Surg 2004, 17:173-180.
78. Hartmann I.J., Hagen P.J., Melissant C.F., et al. Diagnosing acute pulmonary embolism: effect of chronic obstructive pulmonary disease on the performance of D-dimer testing, ventilation/perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism. Am J Respir Crit Care Med 2000, 162:2232-2237.
79. Schulman S., Kearon C., Kakkar A.K., et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009, 361:2342-2352.
80. Lee A.Y., Bauersachs R., Janas M.S., et al. CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients. BMC Cancer 2013, 13:284.
81. Loffredo L., Perri L., Del Ben M., et al. New oral anticoagulants for the treatment of acute venous thromboembolism: are they safer than vitamin K antagonists? A meta-analysis of the interventional trials. Intern Emerg Med 2015, 10(4):499-506.
82. Kameyama K., Huang C.L., Liu D., et al. Pulmonary embolism after lung resection: diagnosis and treatment. Ann Thorac Surg 2003, 76:599-601.
83. Guyatt G.H., Akl E.A., Crowther M., et al. Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141:48s-52s.
84. Agnelli G., George D.J., Kakkar A.K., et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med 2012, 366:601-609.
85. Agnelli G., Verso M. Thromboprophylaxis during chemotherapy in patients with advanced cancer. Thromb Res 2010, 125(Suppl 2):S17-S20.
86. Ma Q., Liu D., Guo Y., et al. Surgical techniques and results of the pulmonary artery reconstruction for patients with central non-small cell lung cancer. J Card Surg 2013, 8:219.
87. Rendina E., Venuta F. Sleeve resection and prosthetic reconstruction of the pulmonary artery for lung cancer. Ann Thorac Surg 1999, 68:995-1001.
88. Alifano M., Cusumano G., Strano S., et al. Lobectomy with pulmonary artery resection: morbidity, mortality, and long-term survival. J Thorac Cardiovasc Surg 2009, 137:1400-1405.
89. Shrager J., Lambright E., McGrath C., et al. Lobectomy with tangential pulmonary artery resection without regard to pulmonary function. Ann Thorac Surg 2000, 70:234-239.
90. Amar D. Prevention and management of perioperative arrhythmias in the thoracic surgical population. Anesthesiol Clin 2008, 26:325-335. vii.
91. Roselli E.E., Murthy S.C., Rice T.W., et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg 2005, 130:438-444.
92. Amar D. Postthoracotomy atrial fibrillation. Curr Opin Anaesthesiol 2007, 20:43-47.
93. Mason D.P., Marsh D.H., Alster J.M., et al. Atrial fibrillation after lung transplantation: timing, risk factors, and treatment. Ann Thorac Surg 2007, 84:1878-1884.
94. Ivanovic J., Maziak D.E., Ramzan S., et al. Incidence, severity and perioperative risk factors for atrial fibrillation following pulmonary resection. Interactive Cardiovasc Thorac Surg 2014, 18:340-346.
95. Neragi-Miandoab S., Weiner S., Sugarbaker D.J. Incidence of atrial fibrillation after extrapleural pneumonectomy vs. pleurectomy in patients with malignant pleural mesothelioma. Interactive Cardiovasc Thorac Surg 2008, 7:1039-1042.
96. Vaporciyan A.A., Correa A.M., Rice D.C., et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 2004, 127:779-786.
97. Stougard J. Cardiac arrhythmias following pneumonectomy. Thorax 1969, 24:568-572.
98. Fernando H.C., Jaklitsch M.T., Walsh G.L., et al. The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary. Ann Thorac Surg 2011, 92:1144-1152.
99. Frendl G., Sodickson A.C., Chung M.K., et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg 2014, 148:e153-e193.
100. Flynn B.C., Vernick W.J., Ellis J.E. β-Blockade in the perioperative management of the patient with cardiac disease undergoing non-cardiac surgery. Br J Anaesth 2011, 107(Suppl 1):i3-i15.
101. Bagshaw S.M., Galbraith P.D., Mitchell L.B., et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg 2006, 82:1927-1937.
102. Bouri S., Shun-Shin M.J., Cole G.D., et al. Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery. Heart 2014, 100:456-464.
103. Cook R.C., Yamashita M.H., Kearns M., et al. Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg 2013, 95:533-541.
104. Amar D., Roistacher N., Rusch V.W., et al. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J Thorac Cardiovasc Surg 2000, 120:790-798.
105. Dehghani M.R., Kasianzadeh M., Rezaei Y., et al. Atorvastatin reduces the incidence of postoperative atrial fibrillation in statin-naive patients undergoing isolated heart valve surgery: a double-blind, placebo-controlled randomized trial. J Cardiovasc Pharmacol Ther 2015, 20(5):465-472.
106. Zheng H., Xue S., Hu Z.L., et al. The use of statins to prevent postoperative atrial fibrillation after coronary artery bypass grafting: a meta-analysis of 12 studies. J Cardiovasc Pharmacol 2014, 64:285-292.
107. Amar D., Zhang H., Heerdt P.M., et al. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest 2005, 128:3421-3427.
108. Lai H.C., Lai H.C., Wang K.Y., et al. Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery. Br J Anaesth 2007, 99:184-190.
109. Ramakrishna G., Sprung J., Ravi B.S., et al. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005, 45:1691-1699.
110. Pritts C.D., Pearl R.G. Anesthesia for patients with pulmonary hypertension. Curr Opin Anaesthesiol 2010, 23:411-416.
111. Minai O.A., Yared J.P., Kaw R., et al. Perioperative risk and management in patients with pulmonary hypertension. Chest 2013, 144:329-340.